Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-150

I don't want to see a pump and dump.

I do want to see CDY priced as a going concern which would be about 3x the current SP.

As posted I don't expect to see a huge margin on each COVID-19 test that is distributed. I wouldn't care if it were one or two dollars a pop because that will keep the team gainfully busy and earning revenue at a time that most companies are not.

As reported, a midkine deal is in the making. I don't know if there is a COVID-19 link or not or whether midkine sequestration is being explored as a means of reducing lung inflammation in severe COVID-19 cases but it should be. Properly conducted research published credible peer reviewed journals points to the possible link between midkine elevation and lung inflammation that leads to the fibrosis we see in many COVID-19 cases.

I don't know what the market will make of the current developments at Midkine. My guess is that the company will ignore any market volatility .